Antipeptide antibodies of predetermined specificity recognize and neutralize the bioactivity of the pan-specific hemopoietin interleukin 3
- PMID: 2433340
Antipeptide antibodies of predetermined specificity recognize and neutralize the bioactivity of the pan-specific hemopoietin interleukin 3
Abstract
Ten peptides that corresponded to portions of the T cell lymphokine pan-specific hemopoietin interleukin 3 (IL 3) were synthesized, coupled to keyhole limpet hemocyanin, and used to raise antipeptide antibodies in rabbits. These antisera reacted to varying degrees with native biologically active IL 3. Antibodies directed against peptides corresponding to residues 1-29 at the NH2 terminus, 123-140 at the COOH terminus, and to residues 64-82 and 91-112 were affinity-purified on peptide columns. Immunoabsorbent columns produced from affinity-purified antibodies to the 1-29, 91-112, and 123-140 although not the 64-82 peptide were effective in depleting biologically active IL 3 from conditioned medium. However, the antibodies specific for peptides 91-112 and 123-140 had only a low affinity for native IL 3 and it was only in the case of the anti-1-29 antibodies that a significant amount of IL 3 remained bound after extensive washing and could be recovered from the column by acid elution. The affinity-purified antibodies directed to peptides 1-29, 91-112, and 123-140 significantly inhibited the biological activity of IL 3, although with different dose-response characteristics. Anti-1-29 antibodies inhibited bioactivity over a wide range of concentrations (down to 20 ng/ml) although the inhibition was never complete. In contrast, the anti-91-112 antibodies, although effective only at high concentrations, produced complete inhibition of biological activity. These experiments demonstrated that antibodies to defined peptides can be used to generate antibodies to native IL 3 and should form useful tools in analyzing the structure and function of the native molecules.
Similar articles
-
Antipeptide antibodies define the NH2-terminal structure of the pan-specific hemopoietin interleukin 3.J Immunol. 1987 Feb 15;138(4):1105-8. J Immunol. 1987. PMID: 2433341
-
Monoclonal antipeptide antibodies recognize IL-3 and neutralize its bioactivity in vivo.J Immunol. 1988 Feb 15;140(4):1182-7. J Immunol. 1988. PMID: 3257773
-
Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.Mol Pharmacol. 1993 May;43(5):666-76. Mol Pharmacol. 1993. PMID: 8502224
-
Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.J Mol Recognit. 1993 Jun;6(2):81-94. doi: 10.1002/jmr.300060206. J Mol Recognit. 1993. PMID: 7508238
-
Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome.Exp Hematol. 1993 Feb;21(2):358-65. Exp Hematol. 1993. PMID: 8425573
Cited by
-
Mutational and functional analysis of dominant SPT2 (SIN1) suppressor alleles in Saccharomyces cerevisiae.Mol Cell Biol. 1993 Sep;13(9):5393-407. doi: 10.1128/mcb.13.9.5393-5407.1993. Mol Cell Biol. 1993. PMID: 8395004 Free PMC article.
-
Intracisternal A-type particle-mediated activations of cytokine genes in a murine myelomonocytic leukemia: generation of functional cytokine mRNAs by retroviral splicing events.Mol Cell Biol. 1991 Nov;11(11):5562-70. doi: 10.1128/mcb.11.11.5562-5570.1991. Mol Cell Biol. 1991. PMID: 1922064 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources